Supplemental breast MRI screening provides a highly sensitive method for detecting early-stage cancer. Doctors frequently recommend this modality for women whose mammograms show extremely dense tissue. Because dense tissue appears white on X-rays, it can obscure underlying malignancies. Therefore, adding MRI helps clinicians identify tumors that traditional screening might miss. A new simulation study explores the long-term impact of these advanced imaging strategies on mortality and costs.
Impact on Breast Cancer Mortality
The study found that digital breast tomosynthesis (DBT) alone saves many lives across all risk groups. However, adding supplemental MRI for women with extremely dense breasts provides additional protection. Specifically, it averted between 0.1 and 0.8 more deaths per 1000 women screened. For patients with a two-fold higher risk, the benefit-to-harm ratio remains favorable. Consequently, these women gain significant survival advantages when doctors integrate MRI into their routine care plans.
Evaluating Supplemental Breast MRI Screening Costs
Economic considerations play a vital role in choosing screening protocols within the healthcare system. The researchers analyzed the incremental cost-effectiveness of various supplemental imaging intervals. They discovered that biennial MRI starting at age 50 is more effective than earlier DBT alone. Nevertheless, the cost-effectiveness depends heavily on the price of the MRI scan itself. If facilities can reduce imaging costs, supplemental MRI becomes a much more viable public health option. Additionally, improving the accuracy of these scans helps lower overall system expenses.
Managing False-Positive Results
Higher sensitivity often comes with a higher risk of false-positive biopsy recommendations. In this study, adding MRI led to 22 to 186 additional false-positive biopsies per 1000 women. These results can cause anxiety and lead to further invasive testing for many patients. Therefore, physicians must carefully weigh these potential harms against the life-saving benefits of early detection. Furthermore, reducing the false-positive rate remains a primary goal for future radiological research and technological development.
Frequently Asked Questions
Q1: Who should consider supplemental breast MRI?
Women with extremely dense breast tissue and a relative risk of breast cancer twice the average or higher may benefit most. This combination offers a favorable balance between cancer detection and potential harms.
Q2: How does breast density affect screening?
Dense breast tissue and tumors both appear white on traditional mammograms. This similarity can hide early signs of cancer, making supplemental tools like MRI necessary for certain high-risk individuals.
References
- Tosteson ANA et al. Outcomes of Density-Targeted Supplemental Breast Magnetic Resonance Imaging Screening by Breast Cancer Risk: Long-Term Health and Economic Considerations. Ann Intern Med. 2026 Mar 03. doi: 10.7326/ANNALS-25-00792. PMID: 41771133.
- Breast Imaging Society, India. Best Practice Guidelines for Breast Imaging. NAMS Annals. 2022.
- National Academy of Medical Sciences (India). Task Force Report on Breast Cancer in India. 2025.